US FDA Authorized Pfizer’s COVID-19 Vaccine Booster Shots for Children Under Five Years
The omicron single-dose booster shot for children under the age of five was approved by Pfizer and its partner BioNTech SE by the US Food and Drug Administration (FDA). According to the agency, children who have already received three doses of the initial vaccine will be eligible for the booster. After receiving the clinical trial […]
Continue Reading